Literature DB >> 30726142

Proliferation of Cash-Only Buprenorphine Treatment Clinics: A Threat to the Nation's Response to the Opioid Crisis.

Art Van Zee1, David A Fiellin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30726142      PMCID： PMC6366517          DOI： 10.2105/AJPH.2018.304899

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  4 in total

1.  Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?

Authors:  Taeho Greg Rhee; Robert A Rosenheck
Journal:  Addiction       Date:  2019-07-25       Impact factor: 6.526

2.  The effect of Medicaid expansion on state-level utilization of buprenorphine for opioid use disorder in the United States.

Authors:  Hannah K Knudsen; Jeanie Hartman; Sharon L Walsh
Journal:  Drug Alcohol Depend       Date:  2022-01-29       Impact factor: 4.492

3.  Buprenorphine Use Trends Following Removal of Prior Authorization Policies for the Treatment of Opioid Use Disorder in 2 State Medicaid Programs.

Authors:  Shailina Keshwani; Michael Maguire; Amie Goodin; Wei-Hsuan Lo-Ciganic; Debbie L Wilson; Juan M Hincapie-Castillo
Journal:  JAMA Health Forum       Date:  2022-06-24

4.  A bifurcated opioid treatment system and widening insidious disparities.

Authors:  Erick G Guerrero; Hortensia Amaro; Tenie Khachikian; Mona Zahir; Jeanne C Marsh
Journal:  Addict Behav       Date:  2022-03-02       Impact factor: 4.591
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.